CIRCULATING LEVELS OF SOLUBLE CD30 ARE INCREASED IN PATIENTS WITH SYSTEMIC SCLEROSIS (SSc) AND CORRELATE WITH SEROLOGICAL AND CLINICAL FEATURES OF THE DISEASE